S
Sergio García-Fernández
Publications - 31
Citations - 478
Sergio García-Fernández is an academic researcher. The author has contributed to research in topics: Medicine & Ceftolozane. The author has an hindex of 11, co-authored 26 publications receiving 280 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals
Sergio García-Fernández,María-Isabel Morosini,Francesc Marco,Desirèe Gijón,Andrea Vergara,Jordi Vila,Patricia Ruiz-Garbajosa,Rafael Cantón +7 more
TL;DR: The eazyplex(®) SuperBug CRE system proved to be a powerful tool for the detection of different carbapenemases as well as CTX-M-type ESBLs in Enterobacteriaceae with a rapid resolution time.
Journal ArticleDOI
Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection - ERRATUM.
Manuel Ponce-Alonso,Javier Sáez de la Fuente,Angela Rincón-Carlavilla,Paloma Moreno-Nunez,Laura Martínez-García,Rosa Escudero-Sánchez,Rosario Pintor,Sergio García-Fernández,Javier Cobo +8 more
TL;DR: The observed reduction of ~70% in the incidence density of HCFA CDI in a context of no reduction in antibiotic use supports the importance of reducing nosocomial transmission by healthcare workers and asymptomatic colonized patients, reinforcing cleaning procedures and reducing patient mobility in the epidemiological control of CDI.
Journal ArticleDOI
Impact of the COVID-19 pandemic on nosocomial Clostridioides difficile infection
Manuel Ponce-Alonso,Javier Sáez de la Fuente,Angela Rincón-Carlavilla,Paloma Moreno-Nunez,Laura Martínez-García,Rosa Escudero-Sánchez,Rosario Pintor,Sergio García-Fernández,Javier Cobo +8 more
TL;DR: In this paper, the authors assessed the impact of the COVID-19 pandemic on the incidence of nosocomial Clostridioides difficile infection (CDI) in the hospital setting.
Journal ArticleDOI
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study.
Sergio García-Fernández,María García-Castillo,Germán Bou,Jorge Calvo,Emilia Cercenado,Mercedes Delgado,Cristina Pitart,Xavier Mulet,Nuria Tormo,Diego López Mendoza,Jazmín Díaz-Regañón,Rafael Cantón +11 more
TL;DR: The in vitro activity of C/T observed in this surveillance study suggests that this agent can be considered as a therapeutic option for cUTI and cIAI due to Enterobacterales and P. aeruginosa in ICU patients, particularly when carbapenemase-producing isolates are not involved.
Journal ArticleDOI
A publicly accessible database for Clostridioides difficile genome sequences supports tracing of transmission chains and epidemics.
Martinique Frentrup,Zhemin Zhou,Matthias Steglich,Jan P. Meier-Kolthoff,Markus Göker,Thomas Riedel,Boyke Bunk,Cathrin Spröer,Jörg Overmann,Jörg Overmann,Marion Blaschitz,Alexander Indra,Lutz von Müller,Thomas Kohl,Stefan Niemann,Christian Seyboldt,Frank Klawonn,Nitin Kumar,Trevor D. Lawley,Sergio García-Fernández,Rafael Cantón,Rosa del Campo,Ortrud Zimmermann,Uwe Groß,Mark Achtman,Ulrich Nübel,Ulrich Nübel +26 more
TL;DR: A publicly accessible database within EnteroBase that automatically retrieves and assembles C. difficile short-reads from the public domain, and calls alleles for core-genome multilocus sequence typing (cgMLST), and Hierarchical clustering rapidly identifies database entries that are related at multiple levels of genetic distance, facilitating communication among researchers, clinicians and public-health officials who are combatting disease caused by C.difficile.